baricitinib,
INCB028050,
LY3009104,
Baricitinib,
1187594-09-7,
INCB028050,
LY3009104,
INCB 028050,
2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile,
INCB-028050,
UNII-ISP4442I3Y,
Baricitinib (LY3009104, INCB028050),
1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile,
LY-3009104,
ISP4442I3Y,
LY 3009104,
INCB 28050,
J-503551,
C16H17N7O2S,
olumiant,
3-AZETIDINEACETONITRILE, 1-(ETHYLSULFONYL)-3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL]-,
Baricitinib [USAN:INN],
Olumiant (TN),
3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-,
baricitinib-ly3009104,
MLS006011247,
SCHEMBL871150,
Baricitinib (JAN/USAN/INN),
Baricitinib (LY3009104),
GTPL7792,
CHEMBL2105759,
AMMD00005,
CHEBI:95341,
DTXSID30152228,
EX-A413,
QCR-197,
XUZMWHLSFXCVMG-UHFFFAOYSA-N,
HMS3651L17,
AOB87724,
BCP04686,
ABP001023,
BDBM50021656,
MFCD21608464,
s2851,
ZINC73069247,
AKOS022186127,
AKOS025401933,
AM81232,
BCP9000380,
CS-0724,
DB11817,
DS-7641,
PB27275,
RL00725,
SB10845,
KS-0000044L,
NCGC00345839-01,
NCGC00345839-14,
AC-27404,
AK143352,
BC600315,
HY-15315,
SC-94301,
SMR004703006,
BCP0726000031,
AB0035958,
AJ-121247,
AX8261519,
Baricitinib (INCB28050 LY3009104),
SW220096-1,
Y0439,
D10308,
S-7686,
(1-(Ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)ethanenitrile,
{1-(ethylsulfonyl)-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]azetidin-3-yl}acetonitrile,
2-(3-(4-(3H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile,
2-[1-ETHYLSULFONYL-3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PYRAZOL-1-YL]AZETIDIN-3-YL]ACETONITRILE,
3JW,
INCB-028050|||LY-3009104|||2-[1-Ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile,
Baricitinib phosphate,
Baricitinib [USAN],
D0Y7IC,
cc-652,
INCB-28050,
A3222,
A4141,
A11329,
C000596027,
1187595-84-1,
1173900-33-8,